A randomised phase 2 study of ASTX727 versus best supportive care in(MDS/MPN) Overlap Syndromes
Latest Information Update: 19 Jun 2024
At a glance
- Drugs Cedazuridine/decitabine (Primary) ; Hydroxycarbamide
- Indications Chronic myelomonocytic leukaemia; Myelodysplastic syndromes; Myeloproliferative disorders
- Focus Therapeutic Use
- Acronyms AMMO
Most Recent Events
- 02 Jun 2022 Status changed from not yet recruiting to recruiting.
- 23 May 2022 New trial record